Cost Effective Treatment for Dually Diagnosed Homeless

This study has been completed.
Sponsor:
Information provided by:
University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00368524
First received: August 23, 2006
Last updated: NA
Last verified: August 2006
History: No changes posted
  Purpose

This randomized controlled trial examined whether an abbreviated treatment using abstinence contingency management for housing and work/training (CM, n=103) with cocaine dependent, non-psychotic, dually diagnosed homeless persons, would show non-inferior outcomes compared to the full treatment (CM+, n=103). It was hypothesized that CM+ would show superior abstinence and retention outcomes, but that CM, with components derived from previously effective behavioral day treatment, would obtain non-inferior outcomes, defined as 75% or more of those observed for the full treatment (CM+) during active treatment months 1-6. The CM+ included all CM components but added behavioral day treatment that included voucher reinforcement of $7.50-15.00, for objective weekly therapeutic goal attainment in five domains of functioning: drug dependence, homelessness, unemployment, non-drug related recreational activities, and behavioral, health, or mental health problems. Abstinence was assessed by observed urine specimen collection and weekly testing weeks 1-52, and randomly, bi-monthly for months 13-18. Abstinence, homelessness, employment and other outcomes were also assessed at baseline, 2, 6, 12, and 18 months.


Condition Intervention
Cocaine Dependence
Mental Disorder
Homelessness
Unemployment
Behavioral: contingency management and behavioral day treatment

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Cost Effective Treatment for Dually Diagnosed Homeless

Resource links provided by NLM:


Further study details as provided by University of Alabama at Birmingham:

Primary Outcome Measures:
  • abused drug abstinence measured by observed urine specimen testing weeks 1-52, and bimonthly months 13-18

Secondary Outcome Measures:
  • abstinence, housing, employment and other outcomes at 0, 2, 6, 12 and 18 months.

Estimated Enrollment: 160
Study Start Date: November 2001
Estimated Study Completion Date: November 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria: McKinney Act criteria for homelessness; DSM IV diagnosis for Cocaine Dependence; self-reported use within the last 2 weeks; psychological distress indicated by score of 70 on 1 or more Brief Symptom Inventory scales; willingness to participate; no plans to move from Birmingham area for 18 months;

-

Exclusion Criteria: cognitive impariment precluding informed consent; requiring immediate inpatient medical treatment

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00368524

Sponsors and Collaborators
University of Alabama at Birmingham
Investigators
Principal Investigator: Jesse B. Milby, Ph.D. ABPP University of Alabama at Birmingham
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00368524     History of Changes
Other Study ID Numbers: F920822004, 1R01DA11789
Study First Received: August 23, 2006
Last Updated: August 23, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:
cocaine dependence
mental disorder
dual diagnoses
homelessness

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Cocaine-Related Disorders
Schizophrenia and Disorders with Psychotic Features
Substance-Related Disorders

ClinicalTrials.gov processed this record on April 17, 2014